Royal Harbor Partners, LLC Abb Vie Inc. Transaction History

Royal Harbor Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $2,752 - $3,499	20 Added 0.7%	2,858 $438,000
Q1 2022 Aug 05, 2022	BUY	$131.98 - $163.75 $2,639 - $3,275	20 Added 0.71%	2,838 $460,000
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $5,320 - $6,039	50 Added 1.81%	2,818 $304,000
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $199,655 - $249,812	2,768 New	2,768 $245,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Royal Harbor Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Harbor Partners, LLC with notifications on news.